PRKAA1 and type 2 diabetes mellitus: Also, research carried by Nyambuya showed that metformin has anti-inflammatory effects by activating the AMPK signaling pathway and inhibiting the mTOR signaling pathway, thereby slowing down the progression of T2D and T2D-related cardiovascular complications [139].